ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 666302 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 666302; 2) Community: the network communities that were significantly associated with the response to NSC 666302; 3) Molecule: the relationships between components within communities and NSC 666302; 4) MDR: the compounds that were significantly associated with the NSC 666302.

NSC Compound Enrichment Correlation
NSC 622282 4H-1-Benzothiopyran-4-one, 2-(methylsulfonyl)- 0.000316069426108864 0.70103602
NSC 623639 Cyclopentane-1,3-dimethanamine, N,N,N,N',N',N'-hexamethyl-2-oxo-, iodide 0.000316069426108864 0.80546693
NSC 624172 Null 0.000316069426108864 0.62324809
NSC 638634 4-Piperidinone, 3,5-bis(phenylmethylene)-1-(1-oxo-3-phenyl- 2-propenyl)- 0.000316069426108864 0.59401888
NSC 639981 Null 0.000316069426108864 0.78301828
NSC 653547 Null 0.000316069426108864 0.74582583
NSC 657822 (1R)-3,3-Dibromocamphor 0.000316069426108864 0.7452455
NSC 22070 Chrysanthin 0.00056892278516733 0.73418076
NSC 295426 Propanoic acid, 2-methyl-, 2,3,3a,4,5,8,9,11a-octahydro-6,10-bis(hydroxymethyl)-3-methylene-2-oxocyclodeca[b]furan-4-yl ester, [3aR-(3aR*,4S*,6Z,10Z,11aR*)]- (9CI) 0.00056892278516733 0.64164222
NSC 81052 Streptonigrin analog (MeO-N3) 0.00060237478588577 0.71334167
Total:76  Current:2    [First] [Prev] [Next] [Last]